GlassScriptPhysician profile
Murray David Robinson
NPI 1750387528
$980.97
in general payments reported to CMS, 2019-2025
13 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $66.40 · 2024: $522 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $172.45 | 2025 | Prolate, Nalocet, Tanlor |
| Stryker Corporation | $172.01 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $149.83 | 2024-2025 | Evoke |
| Abbvie INC. | $124.10 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $80.45 | 2024-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.50 | 2024-2025 | Relistor |
| Biotronik Nro, INC. | $60.95 | 2024-2025 | Prospera |
| Masimo Corporation | $46.45 | 2023 | Patient Safetynet System |
| Avanos Medical | $35.71 | 2024 | Standard Rf Disposables |
| Pacira Pharmaceuticals Incorporated | $19.95 | 2023 | Exparel, Iovera, Zilretta |
| Abbott Laboratories | $19.23 | 2024 | Proclaim |
| Amgen INC. | $17.75 | 2024 | Prolia, Evenity |
| Valinor Pharma, LLC | $17.59 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.